Antibiotic prophylaxis during oral implant surgery in Northwest China

Author:

Lin Yao1,Yue Jiao1,Huang Jing1,Cheng Lifei1,Pan Wen1,Ju Jia1,Wei Hongbo1,Feng Bin1

Affiliation:

1. School of Stomatology, The Fourth Military Medical University

Abstract

Abstract Background There is still no consensus on prophylactic antibiotics in dental implants in China. This study aims to further understand the current status of prophylactic antibiotics in dental implants in China and to provide evidence-based data for the guidelines of prophylactic antibiotic use in dental implants. Methods This study is based on a cross-sectional study of a National dental implant specialist member. The questionnaire survey was conducted from April to December of 2021.It consisted of three parts:the basic information of respondents, the cognitive environment of using prophylactic antibiotics in dental implants in Northwest China, and the use of antibacterial in dental implants.The conclusion was drawn by statistical analysis of the questionnaire survey. Results A total of 318 dentists were surveyed. Approximately 65.41% of respondents generally prescribed antibiotics during dental implant surgery, 33.65% just prescribed antibiotics under certain circumstances,and 0.94% never prescribed antibiotics. The most frequently-used antibiotic classes were penicillin (such as amoxicillin), cephalosporin (such as cefazolin), and nitroimidazole (such as metronidazole). It is common to treat patients with a combination of antibiotics. Furthermore, 55.87% of respondents used antibiotics for more than 24 hours in common dental implants, and 85.08% used antibioticsin dental implants with bone grafts. Conclusions Since there are no standards for regulations about the choice of varieties, dosage, and course of prescribing antibiotics during dental implants, the use of prophylactic antibiotics is largely based on the experience of dentists. Therefore, it’s necessary to formulate guidelines for using antibiotics in dental implants, improve the standardization of antibiotics, and prevent overuse and bacterial resistance.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3